Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort

NCT: NCT06078527 · NOT_YET_RECRUITING

NCT IDNCT06078527
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2029-01-31
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

A previous study completed in 2022 (NCT05158179) was conducted using cohorts of healthy controls, and adults with general laryngopharyngeal disorders. This study will expand on the previous research to include a separate cohort of adults being seen in clinic for an existing laryngopharyngeal disorder resulting from previous radiation or other cancer treatments.

Frequently Asked Questions

What is Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort?

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort is a clinical trial registered under NCT06078527. Current status: NOT_YET_RECRUITING.

What is the status of NCT06078527?

The current status of NCT06078527 (Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort) is: NOT_YET_RECRUITING.

When did Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort start?

Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort started on 2026-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑